PPP5C promotes cell proliferation and survival in human prostate cancer by regulating of the JNK and ERK1/2 phosphorylation
Open Access
- 1 September 2018
- journal article
- research article
- Published by Taylor & Francis in OncoTargets and Therapy
- Vol. ume 11, 5797-5809
Abstract
Background: Prostate cancer (PCa) is one of the most common malignancies and a major leading cause of cancer-related deaths in males. And it is necessary to explore new molecular targets to enhance diagnosis and treatment level of the PCa. Serine/threonine protein phosphatase 5 (PPP5C) is a vital molecule that Involve in complex cell physiological activity. Purpose: The objective of this study was to detecte the expression level of PPP5C in the tissue of prostate cancer patients and further discussed the PPP5C biological function and mechanisms on the PCa. Methods: The expression level of PPP5C was analyzed by immunohistochemistry and ONCOMINE datasets. Lentivirus-mediated short hairpin RNA (shRNA) was constructed to silence the expression of PPP5C in prostate cancer cell. Cell viability and proliferation were measured using MTT and colony formation, and the cell cycle and apoptosis was analyszed by flow cytometry. The changes of downstream protein level and protein phosphorylation level were detected by western blot. Results: PPP5C was highly expressed in PCa tissue as analyzed by immunohistochemistry and ONCOMINE datasets. PPP5C Knockdown inhibited cell proliferation and colony formation in PCa cells. Flow cytometry analysis showed that DU145, PC3 and 22RV1 PCa cells deprived of PPP5C were arrested in G0/G1 phase and became apoptotic. Western blot analysis indicated that PPP5C knockdown could promote JNK and ERK phosphorylation. Conclusion: Our study indicated that the PPP5C may become a new potential diagnostic biomarker and therapeutic target for the PCa.Keywords
This publication has 39 references indexed in Scilit:
- Knockdown of protein phosphatase 5 inhibits ovarian cancer growth in vitroOncology Letters, 2015
- RETRACTION: Inhibition of protein phosphatase 5 (PP5) suppresses survival and growth of colorectal cancer cellsBiotechnology and Applied Biochemistry, 2014
- Novel indoloquinoline derivative, IQDMA, induces G2/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activationLife Sciences, 2009
- Hyperactive Ras in developmental disorders and cancerNature Reviews Cancer, 2007
- Protein phosphatase 5 as a negative key regulator of Raf-1 activationTrends in Endocrinology & Metabolism, 2006
- Requirement of protein phosphatase 5 in DNA-damage-induced ATM activationGenes & Development, 2004
- Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stressThe EMBO Journal, 2001
- Serine/Threonine Protein Phosphatase Type 5 Acts Upstream of p53 to Regulate the Induction of p21WAF1/Cip1 and Mediate Growth ArrestJournal of Biological Chemistry, 1998
- The Tetratricopeptide Repeat Domain of Protein Phosphatase 5 Mediates Binding to Glucocorticoid Receptor Heterocomplexes and Acts as a Dominant Negative MutantJournal of Biological Chemistry, 1996
- Chromosomal Localization and 5′ Sequence of the Human Protein Serine/Threonine Phosphatase 5′ GeneBiochemical and Biophysical Research Communications, 1996